Species of Leishmania genus are intracellular parasites responsible for severe zoonotic diseases worldwide, such as leishmaniasis. In Brazil, the most important species is Leishmania infantum. In the northern region, the state of Pará is notable, with a high number of cases reported in recent years. The second largest number of cases of human visceral leishmaniasis in the region in recent years has been reported in the city of Marabá (Pará state). We investigated the prevalence of L. infantum in domestic dogs from Marabá in Amazon region in Brazil.
Materials and Methods:
A total of 400 blood samples were tested using the dual-path platform chromatographic immunoassay (DPP® CVL—Bio-Manguinhos), and molecular diagnosis based in cathepsin L-like gene, which has better specificity and sensitivity than other similar tests.
Results:
The prevalence of L. infantum was 75.5% (302/400) in the serological test, and 59.25% (237/400) in molecular diagnosis, and 45.5% (182/400) in both tests.
Interpretation and Conclusion:
The results confirmed that the parasite L. infantum was prevalent in the dog population of the studied region and adoption of appropriate public policies are urgently needed.
Get full access to this article
View all access options for this article.
References
1.
AlencarA, PereiraC, CastroI, CardosoA, et al.Deforestation in Amazon Settlements: History, Trends and Opportunities [in Portuguese] 1. ed. Brasilia: IPAM,, 2016:93.
2.
AlvesAS, Mouta-ConfortE, FigueiredoFB, OliveiraRVC, et al.Evaluation of serological cross-reactivity between canine visceral leishmaniasis and natural infection by Trypanosoma caninum. Res Vet Sci, 2012; 3:1329–1333.
BasanoSDA, TarsoP, SoaresHS, CostaAP, et al.Toxoplasma gondii, Neospora caninum and Leishmania amazonensis antibodies in domestic dogs in the western Brazilian Amazon region. Braz J Vet Res Anim Sci, 2016; 53:1.
5.
BenchimolJL, GualandiFC, BarretoDCS, PinheiroLA. Leishmaniasis: its historical configuration in Brazil with emphasis on visceral disease in the 1930s to 1960s [in Portuguese]. Boletim do Museu Paraense Emílio Goeldi. Ciências Humanas, 2019; 14:611–626.
6.
BRASIL. Health Information: Epidemiological Information and morbidity [in Portuguese]. Ministry of Health, Executive Secretariat, Brazil: Datasus, 2020.
7.
BRASIL. Ministry of Health. Surveillance Secretariat in Cheers. Epidemiological Bulletin: Neglected Tropical Diseases [in Portuguese]. Brazil: Special number. 2021. Available at: https://www.gov.br/saude/pt.br/assuntos/media/pdf/2021/marco/3/boletim_especial_doencas_negligenciadas.pdf
8.
BrilhanteAF, LimaL, ZampieriRA, NunesVLB, et al.Leishmania (Viannia) braziliensis type 2 as probable etiological agent of canine cutaneous leishmaniasis in Brazilian Amazon. PLos One, 2019; 14:e0216291.
9.
CardimMFM, GuiradoMM, DiboMR, Chiaravalloti NetoF. Visceral leishmaniasis in the state of Sao Paulo, Brazil: Spatial and space-time analysis. Rev Saude Publica, 2016; 50:1–12.
Conceição-SilvaF, AlvesCR. Leishmaniosis in America [in Portuguese]. Rio de Janeiro, RJ: Fiocruz,, 2014:183–192.
12.
DantasASF, FernandesDNA, CruzER, JuniorJESM, et al. The epidemiological profile of visceral leishmaniasis in the city of Marabá—Pará from 2007 to 2017 [in Portuguese]. Symposium on infectious and parasitic diseases in the Amazon. Belém, Pará, 2019.
13.
FigueiredoFB, Lima JuniorFEF, TomioJE, IndaFMC, et al.Canine visceral leishmaniasis: Two autochthonous cases in Florianópolis Municipality, Santa Catarina State, Brazil. Acta Sci Vet, 2012; 40:1–4.
14.
GontijoCMF, MeloMN. Visceral leishmaniasis in Brazil: current situation, challenges and perspective [in Portuguese]. Rev Bras Epidemiol, 2004; 7:338–349.
15.
HenriquesO. Health: Number of cases of leishmaniasis continues to reduce in Marabá [in Portuguese]. Communication advisory of Marabá. Marabá Prefecture, 2019. Available at https://maraba.pa.gov.br/saude-numero-de-casos-de-leishmaniose-continua-reduzindo-em-maraba (accessed September9, 2020).
16.
LaurentiMD, De Santana Leandro JrMV, TomokaneTY, De LuccaHRL, et al.Comparative evaluation of the DPP(®) CVL rapid test for canine serodiagnosis in area of visceral leishmaniasis. Vet Parasitol, 2014; 3–4:444–450.
17.
LimaJTR, GennariSM, SoaresHS, MinervinoAHH, et al.Serodiagnosis of visceral and cutaneous leishmaniasis in human and canine populations living in Indigenous Reserves in the Brazilian Amazon Region. Rev Soc Bras Med Trop, 2017; 50:61–66.
18.
LimaT, Martinéz-SoguesL, Montserrat-Sangrà S, Solano-Galleno L, et al. Diagnostic performance of a qPCR for Leishmania on stained cytological specimens and on filter paper impressions obtained from cutaneous lesions suggestive of canine leishmaniosis. Vet Dermatol, 2019; 30:318–389.
19.
LobatoMM, EmmiMF. Globalization and spatial restructuring at the border: the impact of the implementation of major works in the city of Marabá—Pará [in Portuguese]. Rev Bras de Geografia Econômica, 2014; 4:1–11.
20.
LopesEG, Sevá AP, Ferreira F, Nunes CM, et al. Serological and molecular diagnostic tests for canine visceral leishmaniasis in Brazilian endemic area: One out of five seronegative dogs are infected. Epidemiol Infect, 2017; 12:2436–2444.
21.
MarciliA, SperançaMA, Da CostaAP, MadeiraMF, et al.Phylogenetic relationships of Leishmania species based on trypanosomatid barcode (SSU rDNA) and gGAPDH genes: Taxonomic revision of Leishmania (L.) infantum chagasi in South America. Infect Genet Evol, 2014; 25:44–51.
22.
MarcondesM, LimaVMF, De AraujoMFL, HiramotoRM, et al.Longitudinal analysis of serological tests officially adopted by the Brazilian Ministry of Health for the diagnosis of canine visceral leishmaniasis in dogs vaccinated with Leishmune®. Vet Parasitol, 2013; 3–4:649–652.
23.
MatsumotoPSS, HiramotoRM, PereiraVBR, CamprigherVM, et al. Impact of the household environment risk for maintenance of natural foci of Leishmania infantum transmission to human and animal hosts in endemic areas for visceral leishmaniasis in Sao Paulo State, Brazil. medRxiv 2021. Available at: http://medrxiv.org/content/early/2021/05/22/2021.05.18.21257380.abstract
24.
Mengatto JuniorEA, OliveiraRCD, SilvaJSV. The municipality of Marabá, PA in front of the EES in the Legal Amazon: evaluation of deforestation rates [in Portuguese]. In: The Challenges of Physical Geography on the Frontier of Knowledge. [s.l.] Institute of Geosciences—Unicamp,, 2017:4976–4987.
25.
PAHO. Pan American Health Organization. PAHO initiative for the elimination of diseases: a policy to apply an integrated and sustainable approach to communicable diseases in the Region of the Americas [in Portuguese]. 57th PAHO Board of Directors, 71st session of the WHO Regional Committee for the Americas; from September 30 to October 4,, 2019; Washington, DC. 2019 (document CD57/7). Available at https://iris.paho.org/bitstream/handle/10665.2/51612/CD57-7-s.pdf?sequence=2&isAllowed=y
26.
PAHO. Pan American Health Organization. Leishmaniasis: epidemiological report of the Americas [in Portuguese]. Available at https://iris.paho.org/bitstream/handle/10665.2/50505/2019-cde-leish-informe-epi-das-americas.pdf?sequence=2&isAllowed=y
27.
PARÁ. Law No. 17,846 of March 29, 2018. Marabá City Hall—Pará [in Portuguese]. 2018. Available at www.governotransparente.com.br/transparencia/documentos/4466490/download/29/Plano_Diretor_Participativo_%2017.846_Mar%C3%A7o_2018.pdf
28.
PRODES. Amazon Deforestation Estimation Project [in Portuguese]. 2020. Available at www.dpi.inpe.br/prodesdigital/prodesmunicipal.php
29.
RancanEA, ChagasEFB, SperançaMA, CarvalhoVCL, et al.Spatio-temporal distribution of human American visceral leishmaniasis in the Western region of Sao Paulo State, from 2004 to 2018. Rev Inst Med Trop Sao Paulo, 2020; 62:1–10.
30.
Saccaro JrN, MationL, SakowskiP. Impact of deforestation on the incidence of diseases in the Amazon [in Portuguese]. Texto pra Discussão—IPEA, 2015.
31.
SantosFJA, NascimentoLCS, SilvaWB, OliveiraPO, et al.First report of canine infection by Leishmania (Viannia) guyanensis in the Brazilian Amazon. Int J Environ Res Public Health, 2020; 17:8488.
32.
SilvaEF, Pereira JrJAS, PenaHW. The analysis of the export performance of the main products of the municipality of Marabá in relation to regional dynamism and the structure of Brazilian exports through the competitiveness matrix, 2015–2016 [in Portuguese]. Rev Obs de la Econ Latinoamericana. 2018. Available at https://www.eumed.net/rev/oel/2018/11/exportacoes-brasil-competitividade.html
33.
SilvaRE, SampaioBM, TonhosoloR, Da CostaAP, et al.Exploring Leishmania infantum cathepsin as a new molecular marker for phylogenetic relationships and visceral leishmaniasis diagnosis. BMC Infect Dis, 2019; 19:895.
34.
SINAN. Health Surveillance Secretariat. Epidemiological Bulletin: Neglected Tropical Diseases. Department of Epidemiological Surveillance [in Portuguese]. Surveillance Ed. Ministry of Health, Brasilia, 2021. Available at https://www.gov.br/saude/pt-br/media/pdf/2021/marco/3/boletim_especial_doencas_negligenciadas.pdf
35.
Solano-GallegoL, CardosoL, PennisiMG, PetersenC, et al.Diagnostic challenges in the era of canine Leishmania infantum vaccines. Trends Parasitol, 2017; 9:706–717.
TraviBL, Cordeiro-Da-SilvaA, Dantas-TorresF, Miró G. Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us. PLoS Negl Trop Dis, 2018; 1:12.
38.
Veiga GonçalvesN, MirandaCSC, CostaRJF, GuedesJA, et al.Cutaneous leishmaniasis: Spatial distribution and environmental risk factors in the state of Pará, Brazilian Eastern Amazon. J Infect Dev Ctries, 2019; 13:939–944.
39.
VilelaML, AfonsoMM, CostaSM, CostaWA, et al.Lutzomyia (Lutzomyia) longipalpis: factors associated with the process of expansion and urbanization of American visceral leishmaniasis [in Portuguese]. In: Conceição-SilvaF, AlvesCR, eds. Leishmaniasis of the American. Rio de Janeiro, RJ: Fiocruz, 2014:183–192.
40.
WHO. World Healh Organization. Leishmaniasis. Genebra. 2020a. Available at https://www.who.int/news--room/fact-sheets/detail/leishmaniasis
41.
WHO. World Health Organization. Ending neglect to achieve sustainable development goals: a roadmap for neglected tropical diseases 2021–2030 [in Portuguese]. Genebra: WHO, 2020b. Available at https://apps.who.int/iris/handle/10665/332421
